Söndag 23 Februari | 22:50:26 Europe / Stockholm

Prenumeration

2025-02-20 08:05:00

Redeye updates its view on Nanologica following the year-end report and recent news flow. While maintaining a positive stance on the case, we lower our near-term sales projections and slightly trim our fair value range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/